Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cambridge Major Goes To American Capital

by Rick Mullin
January 7, 2013 | A version of this story appeared in Volume 91, Issue 1

Private equity firm American Capital has acquired Cambridge Major Laboratories, a Wisconsin-based contract manufacturer of active pharmaceutical ingredients, for $212 million. The seller is Arlington Capital, a private equity firm that bought a majority stake in CML in 2007. CML recently completed an expansion of its facility in Germantown, Wis. “American Capital’s financial and operational resources will allow us to expand our market presence in the U.S. and internationally,” says CML CEO Brian Scanlan.

Article:

This article has been sent to the following recipient:

1 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.